256 related articles for article (PubMed ID: 25680276)
1. Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection.
Wieland A; Shashidharamurthy R; Kamphorst AO; Han JH; Aubert RD; Choudhury BP; Stowell SR; Lee J; Punkosdy GA; Shlomchik MJ; Selvaraj P; Ahmed R
Immunity; 2015 Feb; 42(2):367-378. PubMed ID: 25680276
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection.
Yamada DH; Elsaesser H; Lux A; Timmerman JM; Morrison SL; de la Torre JC; Nimmerjahn F; Brooks DG
Immunity; 2015 Feb; 42(2):379-390. PubMed ID: 25680277
[TBL] [Abstract][Full Text] [Related]
3. Enhancing FcγR-mediated antibody effector function during persistent viral infection.
Wieland A; Kamphorst AO; Valanparambil RM; Han JH; Xu X; Choudhury BP; Ahmed R
Sci Immunol; 2018 Sep; 3(27):. PubMed ID: 30242080
[TBL] [Abstract][Full Text] [Related]
4. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.
Straub T; Schweier O; Bruns M; Nimmerjahn F; Waisman A; Pircher H
Eur J Immunol; 2013 Sep; 43(9):2338-48. PubMed ID: 23749409
[TBL] [Abstract][Full Text] [Related]
5. Residual LCMV antigen in transiently CD4
Schweier O; Aichele U; Marx AF; Straub T; Verbeek JS; Pinschewer DD; Pircher H
Eur J Immunol; 2019 Apr; 49(4):626-637. PubMed ID: 30636035
[TBL] [Abstract][Full Text] [Related]
6. Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement.
Richter K; Oxenius A
Eur J Immunol; 2013 Sep; 43(9):2349-60. PubMed ID: 23749374
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes: not just an innocent bystander in chronic viral infection.
Wang TT; Ravetch JV
Immunity; 2015 Feb; 42(2):213-215. PubMed ID: 25692698
[TBL] [Abstract][Full Text] [Related]
8. LCMV-specific CD4 T cell dependent polyclonal B-cell activation upon persistent viral infection is short lived and extrafollicular.
Greczmiel U; Kräutler NJ; Borsa M; Pedrioli A; Bartsch I; Richter K; Agnellini P; Bedenikovic G; Oxenius A
Eur J Immunol; 2020 Mar; 50(3):396-403. PubMed ID: 31724162
[TBL] [Abstract][Full Text] [Related]
9. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.
Planz O; Ehl S; Furrer E; Horvath E; Bründler MA; Hengartner H; Zinkernagel RM
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6874-9. PubMed ID: 9192659
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13.
Luft O; Khattar R; Farrokhi K; Ferri D; Yavorska N; Zhang J; Sadozai H; Adeyi O; Chruscinski A; Levy GA; Selzner N
Immunology; 2018 Jul; 154(3):476-489. PubMed ID: 29341118
[TBL] [Abstract][Full Text] [Related]
11. B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection.
Misumi I; Whitmire JK
J Immunol; 2014 Feb; 192(4):1597-608. PubMed ID: 24453250
[TBL] [Abstract][Full Text] [Related]
12. Role of viral strains and host genes in determining levels of immune complexes in a model system: implications for HIV infection.
Tishon A; Salmi A; Ahmed R; Oldstone MB
AIDS Res Hum Retroviruses; 1991 Dec; 7(12):963-9. PubMed ID: 1812945
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
[TBL] [Abstract][Full Text] [Related]
14. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
[TBL] [Abstract][Full Text] [Related]
15. Interrogating Adaptive Immunity Using LCMV.
Dangi T; Chung YR; Palacio N; Penaloza-MacMaster P
Curr Protoc Immunol; 2020 Sep; 130(1):e99. PubMed ID: 32940427
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression.
Welsh RM; Oldstone MB
J Exp Med; 1977 Jun; 145(6):1449-68. PubMed ID: 301173
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key.
Bachmann MF; Hunziker L; Zinkernagel RM; Storni T; Kopf M
Eur J Immunol; 2004 Feb; 34(2):317-26. PubMed ID: 14768036
[TBL] [Abstract][Full Text] [Related]
18. Dynamics and magnitude of virus-induced polyclonal B cell activation mediated by BCR-independent presentation of viral antigen.
Jellison ER; Guay HM; Szomolanyi-Tsuda E; Welsh RM
Eur J Immunol; 2007 Jan; 37(1):119-28. PubMed ID: 17163452
[TBL] [Abstract][Full Text] [Related]
19. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
[TBL] [Abstract][Full Text] [Related]
20. Immunity to lymphocytic choriomeningitis virus in B cell-depleted mice: evidence for B cell and antibody-independent protection by memory T cells.
Cerny A; Huegin AW; Sutter S; Bazin H; Hengartner HH; Zinkernagel RM
Eur J Immunol; 1986 Aug; 16(8):913-7. PubMed ID: 3488911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
